CirrhoCare Study to Evaluate Digital Home Monitoring and Management for Adults with Decompensated Cirrhosis

What this Trial Is About

Researchers are evaluating a new digital home monitoring and management system called CirrhoCare for patients with decompensated cirrhosis, a serious liver condition caused by scarring from factors such as alcohol, fatty liver, and viral infections. This trial aims to assess the clinical and cost-effectiveness of CirrhoCare compared to the current standard of care. Cirrhosis leads to serious complications and frequent hospital visits, and this study addresses the need for better community-based care through innovative technology. The CirrhoCare system includes clinical-grade monitoring devices such as an Apple watch, a smartphone app, a blood pressure monitor, a weighing scale, and a thermometer. These devices collect vital signs and other health data daily, which are securely transmitted to a clinical dashboard. The system uses hepatic algorithms to help liver specialists identify risks and personalize treatment. Participants are randomly assigned to either receive this digital monitoring system or continue with standard care. Participants will be involved for at least 90 days after randomization, during which researchers will monitor hospital interventions, liver-related complications, hospital readmissions, mortality, quality of life, frailty, and user experience. Data will be collected through the app and clinical assessments to evaluate the effectiveness of CirrhoCare. The study also includes health economic analyses to determine cost-effectiveness and aims to support future adoption of this technology in healthcare services.

CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis